temozolomide has been researched along with ovatodiolide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamodu, OA; Hsiao, M; Lin, CM; Su, YK; Tzeng, YM; Yeh, CT | 1 |
1 other study(ies) available for temozolomide and ovatodiolide
| Article | Year |
|---|---|
Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; beta Catenin; Cell Line, Tumor; Diterpenes; Down-Regulation; Glioblastoma; Humans; Janus Kinase 2; Neoplastic Stem Cells; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; SOXB1 Transcription Factors; STAT3 Transcription Factor; Temozolomide | 2019 |